MedPath
NMPA Approval

Doxofylline Injection

国药准字H20253302

January 24, 2025

Drug Information

多索茶碱注射液

注射剂

10ml:0.1g

化学药品

January 24, 2025

Company Information

Applicant Company

济宁高新区第七工业园

Manufacturing Company

济宁高新区黄屯镇第七工业园A区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath